氘可来昔替尼(Deucravacitinib)不同版本一盒的最新价格公布

Introduction: Deucravacitinib is a highly selective, orally bioavailable, allosteric TYK2 inhibitor for the treatment of autoimmune diseases. It selectively binds to the TYK2 pseudokinase (JH2) domain (IC50=1.0nM) and stabilizes regulatory JH2 Domain to block receptor-mediated activation of Tyk2 and can be used for the treatment of moderate to severe plaque psoriasis.

The latest prices for a box of different versions of Deucravacitinib are announced

The prices of the original research version and the generic version are different. The following prices are for reference only.

1. Original research version: It is currently understood that the original research version of deuterated colexitinib has been launched in China and has been included in medical insurance. The winning bid price for medical insurance is 950$. The price after medical insurance reimbursement will be cheaper, and it needs to be calculated according to the reimbursement ratio of each region.

2. Generic version: There are many manufacturers of generic versions of deuterated colexitinib, and their prices are also different. For example, the price of a box of generic deuterated colexitinib from Ziska Pharmaceutical Factory in Bangladesh is about 550$-800$.

It may fluctuate due to changes in the market and purchase time. For specific prices, it is recommended to consult your local pharmacy or official channels for the latest price information. At the same time, you must understand the specific usage, dosage, side effects, etc. of the drug to ensure safe use.

Dosage of Deucravacitinib

The usual adult dose of Deucravacitinib for the treatment of plaque psoriasis is 6 mg, taken orally once daily. Patients should follow their healthcare provider's instructions exactly. Tablets may be taken with or without food. Tablets need to be swallowed whole. Do not crush, cut, or chew tablets.

Side effects of Deucravacitinib

The most common side effects of Deucravacitinib include upper respiratory tract infections, such as colds, sore throats or sinus infections, herpes simplex, oral ulcers, folliculitis, acne, etc. Deuterated colexitinib may also cause serious side effects, including severe allergic reactions, infections, and more. If you experience any of the following severe allergic reaction symptoms such as swelling of the face, eyelids, lips, mouth, tongue or throat, difficulty breathing, chest tightness, etc., please stop treatment immediately and seek emergency medical help.

Deuterated colexitinib is not suitable for use in patients with active serious infections, including localized infections. You should not start taking deuterated colexitinib if you have any type of infection.